Glucagon is a peptide hormone that increases blood glucose by stimulating hepatic glycogen breakdown. Used in hypoglycemia emergencies. Side effects include nausea, vomiting, and transient blood pressure changes.
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
ID 26266 is a research‑grade compound that demonstrates a multi‑layered biochemical activity profile. Its effects arise through coordinated modulation of enzymatic cascades, high‑affinity receptor binding, post‑translational regulation and structural interactions with intracellular effector molecules. At the cellular level, the compound influences phosphorylation–dephosphorylation cycles, alters mitochondrial bioenergetics, rebalances oxidative stress pathways, and modulates calcium‑dependent signalling nodes. Its mechanistic footprint extends into transcriptional regulatory networks, where it can affect chromatin accessibility, gene expression stability, and the activation threshold of stress‑response transcription factors.
Depending on concentration, exposure duration and cellular phenotype, the compound may act as a signal amplifier, a selective inhibitor of metabolic bottlenecks, or a regulatory dampener for hyperactive pathways. Its physiochemical structure suggests steric complementarity to enzyme pockets, with likely engagement of hydrogen‑bond networks and hydrophobic stabilization forces influencing downstream activity.
This compound offers broad utility across biochemical, cellular and preclinical research domains. Its reproducible mechanistic behaviour makes it suitable for:
Because of its predictable biochemical footprint, the compound is frequently used as a reference standard for assessing new molecular candidates, benchmarking pathway perturbation sensitivity and calibrating screening platforms.
Observed or theoretically predicted risks include mitochondrial overload, disruption of redox homeostasis, membrane‑integrity perturbation and unscheduled apoptosis or autophagy induction at high doses. Off‑target receptor binding may modify unintended signalling axes such as MAPK, JNK, NF‑κB or PI3K/AKT pathways. Chronic or excessive exposure may influence calcium flux, impair proteostasis, or interfere with cytoskeletal dynamics.
Use of the compound should be limited to controlled laboratory environments with appropriate biosafety measures, including dose titration, controlled handling procedures and protective containment. It is not intended for human or veterinary use.
3D viewer laden…
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
Download
